Fritextsökning
Innehållstyper
-
He is zooming in on topical preparations
According to Zelmic CEO David Sagna, topical products in drug development is a growing market, and to keep pace with the development, the company is awaiting ap...
-
Study names with an attitude – more important than you might think
Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.
-
New drug alert in the US: Rise in overdoses linked to the use of drugs for animals
A combination of the synthetic drugs fentanyl and xylazine, an animal tranquilizer, has been labelled a “growing threat” by the White House due to its role in t...
-
Swedish breakthrough in Alzheimer’s: “We can finally present great data”
Treatments for Alzheimer’s disease are currently among the hottest topics in drug development. Two Swedish research companies with high ambitions and successes ...
-
Första vaccinet mot fruktad myggspriden sjukdom godkänt i USA
Det första vaccinet mot chikungunya-viruset, som är ett växande problem framförallt i tropiska och subtrobiska länder, har nu godkänts av den amerikanska läkeme...
-
Decades of research destroyed at KI – a hacker attack cannot be ruled out!
Years of research, together with half a billion Swedish krona, went up in smoke when the freezers at Karolinska Institutet overheated. The breakdown has now bee...
-
He is heading a new company for the development of Coegin’s cancer drug
The biotechnology company Coegin Pharma places the development of its drug candidate AVX420 in a newly formed company, Avexxin Oncology, based in Norway, and Jo...
-
Björn Arvidsson: “We need robust and recognized ecosystems for continued competitiveness”
“We have idea carriers and excellent innovation opportunities, and now we must invest in creating ecosystems that provide them with even better growth opportuni...
-
"Are we doing business the wrong way around in the Life Science Sector?"
For the past 50 years we have created solutions for problems that we thought would solve the problems. Pharmaceuticals have created big block buster drugs which...
-
“Photon counting in computed tomography is the holy grail”
Erik Fredenberg, a researcher in physics at KTH and GE, is working to implement photon-counting CT in clinics. To shorten lead times and reduce the radiation do...
-
No demand for new Covid vaccine – “It will probably be discarded”
So far, just under 6 000 doses of the Covid vaccine from Novavax have been used in Sweden, leaving over 1.4 million doses in stock. “They will probably be disca...
-
Major advances in IVF labs in the last few decades
Since the introduction of in vitro fertilisation several decades ago, many developments have been made in the field, and the main part of that development has t...
-
Han får vetenskapspris för upptäckten av den inflammatoriska reflexen
Den amerikanske neurokirurgen och uppfinnaren Kevin J. Tracey tilldelas Hans Wigzells Forskningsstiftelses vetenskapliga pris på 100 000 dollar. Han får det bla...
-
Neanderthal genes and Nobel Prize in a popular lecture at Bioscience
An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...
-
Nordic Regulatory experts: Improving biotech chances of Succ
Why is it that so many biotech companies fail? And what are the tools needed to change that fact?
-
Column: ”Cheating with pea flowers and does it matter whether you are right?”
Is it possible to forgive shortcuts or outright cheating in science - if it turns out that the researcher was ultimately right? Anna Törner discuss this topic in a column.
-
Conference on Alzheimer’s reveals several advances in the field
In Gothenburg, Sweden, researchers and pharmaceutical companies from all over the world gathered to discuss one specific issue – neurological diseases. Life Sci...
-
Novavax is developing a vaccine candidate against Covid-19 and seasonal flu
A combined vaccine against both Covid-19 and seasonal flu is showing promising results in studies, according to the American drug developer Novavax. The adjuvan...
-
Biosimilars bring price pressure, but are they sufficiently used?
When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...
-
Save time and money !
Festo Digital engineering tools helps you to calculate the most cost and efficient solution for your application for free
-
MedVasc and Scientific Solutions join forces to streamline FDA 510(k) regulatory process
MedVasc, an exciting MedTech startup company, and Scientific Solutions, a renowned consulting firm within Life Science, are pleased to announce a strategic part...
-
“We are Europe’s hotspot in life science”
The Medicon Valley Alliance has worked for competence development in life science in Denmark and Sweden for a quarter of a century. Anette Steenberg, CEO, sees ...
-
Webinar: How to Plan And Analyze a Real-World Evidence Study
This webinar is for drug developers who want to understand the basic ideas of analyzing an RWE study, as well as avoiding the most common pitfalls.
-
Nya data från Medivir vid cancerkongress
Forskningsbolaget Medivir har presenterat data för en trippelkombination med läkemedelskandidaten fostrox vid kongressen AACR 2023.